Novartis CEO: We’re Moving Toward Filing Covid Drug From Molecular Partners With FDA
January 12 2022 - 11:31AM
ValueWalk
Following is the unofficial transcript of a CNBC exclusive
interview with Novartis (NYSE:NVS) CEO Dr. Vas Narasimhan on CNBC’s
“Squawk on the Street” (M-F 9AM – 11AM ET) today, Wednesday,
January 12th. Following is a link to video on CNBC.com: Q4 2021
hedge fund letters, conferences and more Novartis CEO: We’re Moving
Toward Filing Covid […]
https://www.valuewalk.com/novartis-ceo-were-moving-toward-filing-covid-drug-from-molecular-partners-with-fda/
Novartis (NYSE:NVS)
Historical Stock Chart
From Apr 2024 to May 2024
Novartis (NYSE:NVS)
Historical Stock Chart
From May 2023 to May 2024